Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01571427 · ClinicalTrials.gov registry record · Early Phase 1
Conversations as a Means to Delay the Onset of Alzheimer's Disease
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 83
- Enrollment target
NCT01571427 is a Early Phase 1 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 83 participants.
The verdict
NCT01571427, a Early Phase 1 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 83 participants
- Enrollment target
Study Summary
Past epidemiological studies have demonstrated that larger social networks, or more frequent social interactions, could have potential protective effects on the incidence of Alzheimer's Disease (AD). However, in those studies, indicators of social interactions were often broad, and included distinct elements that affected cognition and overall health. This project will examine whether conversation-based cognitive stimulation has positive effects on domain-specific cognitive functions among the elderly. Face-to-face communication will be conducted through the use of personal computers, webcams, and user-friendly simple interactive Internet programs to allow participants to have social engagement while staying at their home and also for the cost effective execution of the study.
Interventions
- BEHAVIORAL Control group
- BEHAVIORAL Active social engagement group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2012-02 |
| Est. Completion | 2013-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01571427
The ClinicalTrials.gov registry entry for NCT01571427 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control group is the first listed.
NCT01571427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01571427 about?
NCT01571427 is a clinical study titled "Conversations as a Means to Delay the Onset of Alzheimer's Disease". Past epidemiological studies have demonstrated that larger social networks, or more frequent social interactions, could have potential protective effects on the incidence of Alzheimer's Disease (AD). However, in those studies, indicators of social interactions were often broad, and included distinct...
What is the current status of trial NCT01571427?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 83 participants. The study started on 2012-02. Estimated completion is 2013-09.
What interventions are being tested in trial NCT01571427?
The interventions under investigation include: Control group (BEHAVIORAL), Active social engagement group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01571427?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.